Latest News of ADCT
ADC Therapeutics SA (NYSE:ADCT) Shares Could Be 50% Below Their Intrinsic Value Estimate
By Yahoo! Finance |
3 months ago
The analyst's price target for ADC Therapeutics is 59% higher than their estimated fair value. A Discounted Cash Flow model is used to determine the intrinsic value of the stock, showing it to be unde...